-
EP0637956
European procedure
Extract from the Register of European Patents
EP About this file: EP0637956
| EP0637956 - USE OF REMACEMIDE FOR THE TREATMENT OF PARKINSON'S DISEASE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.04.2000 Database last updated on 06.07.2024 | Most recent event Tooltip | 28.04.2000 | No opposition filed within time limit | published on 14.06.2000 [2000/24] | Applicant(s) | For all designated states Astra Aktiebolag 151 85 Södertälje / SE | [1999/26] |
| Former [1995/48] | For all designated states Astra Aktiebolag S-151 85 Södertälje / SE | ||
| Former [1995/07] | For all designated states FISONS CORPORATION Jefferson Road P.O. Box 1710 Rochester, New York 14603 / US | Inventor(s) | 01 /
JOHNSON, Peter, Chasewood House Woodside Aspley Guise Bedfordshire MK17 8ER / GB | 02 /
WATKINS, Barry, Ernest 46 Briggsboro Lane Fairport, NY 14450 / US | 03 /
HARRIS, Eric, William 208 Castleman Road Rochester, NY 14620 / US | [1999/25] |
| Former [1995/07] | 01 /
JOHNSON, Peter Chasewood House Woodside Aspley Guise Bedfordshire MK17 8ER / GB | ||
| 02 /
WATKINS, Barry, Ernest 46 Briggsboro Lane Fairport, NY 14450 / US | |||
| 03 /
HARRIS, Eric, William 208 Castleman Road Rochester, NY 14620 / US | Representative(s) | Summersell, Richard John, et al Astra AB, Patent Department 151 85 Södertälje / SE | [N/P] |
| Former [1997/34] | Summersell, Richard John, Dr., et al Astra AB, Patent Department 151 85 Södertälje / SE | ||
| Former [1996/29] | England, Christopher David, et al Astra AB, Patent Department 151 85 Södertälje / SE | ||
| Former [1996/17] | Craig, Christopher Bradberry, et al Fisons plc 12 Derby Road Loughborough Leicestershire LE11 0BB / GB | ||
| Former [1995/48] | Wright, Robert Gordon McRae, et al Astra Patents PO Box 86 Loughborough, Leics. LE11 ORJ / GB | ||
| Former [1995/07] | Wright, Robert Gordon McRae FISONS plc 12 Derby Road Loughborough Leicestershire LE11 0BB / GB | Application number, filing date | 93911903.8 | 30.04.1993 | [1995/07] | WO1993GB00908 | Priority number, date | GB19920009599 | 02.05.1992 Original published format: GB 9209599 | [1995/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9321910 | Date: | 11.11.1993 | Language: | EN | [1993/27] | Type: | A1 Application with search report | No.: | EP0637956 | Date: | 15.02.1995 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.11.1993 takes the place of the publication of the European patent application. | [1995/07] | Type: | B1 Patent specification | No.: | EP0637956 | Date: | 30.06.1999 | Language: | EN | [1999/26] | Search report(s) | International search report - published on: | EP | 11.11.1993 | Classification | IPC: | A61K31/165, A61K31/195 | [1995/07] | CPC: |
A61K31/165 (EP,KR);
A61K31/195 (EP,KR);
A61P25/16 (EP);
A61P25/28 (EP)
| C-Set: |
A61K31/195, A61K2300/00 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1995/07] | Title | German: | VERWENDUNG VON REMACEMID ZUR BEHANDLUNG DES MORBUS PARKINSON | [1999/25] | English: | USE OF REMACEMIDE FOR THE TREATMENT OF PARKINSON'S DISEASE | [1995/07] | French: | UTILISATIION DE REMACEMIDE DANS LE TRAITEMENT DE LA MALADIE DE PARKINSON | [1995/07] |
| Former [1995/07] | Verwendung von Remacemid zur Behandlung des Morbus Parkinson | Entry into regional phase | 10.11.1994 | National basic fee paid | 10.11.1994 | Designation fee(s) paid | 10.11.1994 | Examination fee paid | Examination procedure | 28.05.1993 | Request for preliminary examination filed International Preliminary Examining Authority: FR | 10.11.1994 | Examination requested [1995/07] | 25.03.1998 | Despatch of a communication from the examining division (Time limit: M04) | 09.05.1998 | Reply to a communication from the examining division | 25.06.1998 | Despatch of a communication from the examining division (Time limit: M04) | 06.08.1998 | Reply to a communication from the examining division | 24.11.1998 | Despatch of communication of intention to grant (Approval: Yes) | 21.12.1998 | Communication of intention to grant the patent | 01.03.1999 | Fee for grant paid | 01.03.1999 | Fee for publishing/printing paid | Opposition(s) | 31.03.2000 | No opposition filed within time limit [2000/24] | Fees paid | Renewal fee | 13.04.1995 | Renewal fee patent year 03 | 09.04.1996 | Renewal fee patent year 04 | 07.04.1997 | Renewal fee patent year 05 | 14.04.1998 | Renewal fee patent year 06 | 15.04.1999 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]EP0427427 (FISONS CORP [US]); | [Y]EP0434173 (SCHERING AG [DE]) | [Y] - ANNALS OF NEUROLOGY vol. 28, no. 4, 1990, pages 539 - 546 KLOCKGETHER, T. ET AL 'NMDA ANTAGONISTS POTENTIATE ANTIPARKINSONIAN ACTIONS OF L-DOPA IN MONOAMINE DEPLETED RATS' cited in the application | [Y] - ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY vol. 201, no. 1-2, 1991, page 22 GRIFFITH, R. ET AL 'PRECLINICAL NEUROPROTECTIVE PROFILE OF REMACEMIDE, A PRODRUG NMDA ANTAGONIST' | [XP] - SOC. NEUROSCI. ABSTR. vol. 18, no. 1-2, 1992, page 1080 ELLER, R.V. ET AL 'REMACEMIDE AND L DOPA SYNERGIZE TO REVERSE AKINESIA IN MONOAMINE-DEPLETED RATS' |